Revenue: As of FY2026 Q3, the actual value is USD 5.004 M, missing the estimate of USD 5.256 M.EPS: As of FY2026 Q3, the actual value is USD 0.02, missing the estimate of USD 0.025.EBIT: As of FY2026 Q3, the actual value is USD 210.49 K.<h4>Segment Revenue by Product Line (Nine Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Fluxing Systems revenue increased by $259,000 (80%) to $583,000 in 2025 from $324,000 in 2024.</li><li>In-Line Coating Systems revenue increased by $3,578,000 (126%) to $6,428,000 in 2025 from $2,850,000 in 2024.</li><li>Multi-Axis Coating Systems revenue decreased by -$3,785,000 (-46%) to $4,373,000 in 2025 from $8,158,000 in 2024.</li><li>OEM Systems revenue increased by $140,000 (18%) to $936,000 in 2025 from $796,000 in 2024.</li><li>Other revenue decreased by -$275,000 (-8%) to $2,980,000 in 2025 from $3,255,000 in 2024.</li><li>Total Net Sales decreased by -$83,000 (-1%) to $15,300,000 in 2025 from $15,383,000 in 2024.</li></ul><h4>Segment Revenue by Product Line (Three Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Fluxing Systems revenue increased by $151,000 (213%) to $222,000 in 2025 from $71,000 in 2024.</li><li>In-Line Coating Systems revenue increased by $1,763,000 (2,177%) to $1,844,000 in 2025 from $81,000 in 2024.</li><li>Multi-Axis Coating Systems revenue decreased by -$1,897,000 (-53%) to $1,666,000 in 2025 from $3,563,000 in 2024.</li><li>OEM Systems revenue increased by $166,000 (64%) to $425,000 in 2025 from $259,000 in 2024.</li><li>Other revenue decreased by -$370,000 (-30%) to $847,000 in 2025 from $1,217,000 in 2024.</li><li>Total Net Sales decreased by -$187,000 (-4%) to $5,004,000 in 2025 from $5,191,000 in 2024.</li></ul><h4>Segment Revenue by Market Sales (Nine Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Electronics/Microelectronics sales decreased by -$374,000 (-9%) to $3,686,000 in 2025 from $4,060,000 in 2024.</li><li>Medical sales increased by $793,000 (37%) to $2,949,000 in 2025 from $2,156,000 in 2024.</li><li>Alternative Energy sales decreased by -$148,000 (-2%) to $7,592,000 in 2025 from $7,740,000 in 2024.</li><li>Emerging R&amp;D and Other sales increased by $8,000 (14%) to $65,000 in 2025 from $57,000 in 2024.</li><li>Industrial sales decreased by -$362,000 (-26%) to $1,008,000 in 2025 from $1,370,000 in 2024.</li></ul><h4>Segment Revenue by Market Sales (Three Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Electronics/Microelectronics sales increased by $271,000 (27%) to $1,287,000 in 2025 from $1,016,000 in 2024.</li><li>Medical sales increased by $239,000 (27%) to $1,136,000 in 2025 from $897,000 in 2024.</li><li>Alternative Energy sales decreased by -$1,047,000 (-35%) to $1,912,000 in 2025 from $2,959,000 in 2024.</li><li>Emerging R&amp;D and Other sales increased by $1,000 (6%) to $18,000 in 2025 from $17,000 in 2024.</li><li>Industrial sales increased by $349,000 (116%) to $651,000 in 2025 from $302,000 in 2024.</li></ul><h4>Segment Revenue by Geographic Sales (Nine Months Ended November 30, 2025 vs. 2024)</h4><ul><li>U.S. &amp; Canada sales increased by $265,000 (3%) to $9,674,000 in 2025 from $9,409,000 in 2024.</li><li>Asia Pacific (APAC) sales increased by $268,000 (13%) to $2,262,000 in 2025 from $1,994,000 in 2024.</li><li>Europe, Middle East, Asia (EMEA) sales decreased by -$311,000 (-9%) to $3,027,000 in 2025 from $3,338,000 in 2024.</li><li>Latin America sales decreased by -$305,000 (-48%) to $337,000 in 2025 from $642,000 in 2024.</li></ul><h4>Segment Revenue by Geographic Sales (Three Months Ended November 30, 2025 vs. 2024)</h4><ul><li>U.S. &amp; Canada sales increased by $592,000 (21%) to $3,415,000 in 2025 from $2,823,000 in 2024.</li><li>Asia Pacific (APAC) sales decreased by -$380,000 (-34%) to $734,000 in 2025 from $1,114,000 in 2024.</li><li>Europe, Middle East, Asia (EMEA) sales decreased by -$251,000 (-26%) to $706,000 in 2025 from $957,000 in 2024.</li><li>Latin America sales decreased by -$148,000 (-50%) to $149,000 in 2025 from $297,000 in 2024.</li></ul><h4>Operational Metrics (Nine Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Gross Profit increased by $452,000 (6%) to $7,766,000 in 2025 from $7,314,000 in 2024, with gross profit percentage at 51% in 2025 compared to 48% in 2024.</li><li>Operating Income increased by $501,000 (69%) to $1,223,000 in 2025 from $722,000 in 2024, with operating margin at 8% in 2025 compared to 5% in 2024.</li><li>Net Income increased by $303,000 (32%) to $1,249,000 in 2025 from $946,000 in 2024.</li><li>Research and Product Development Costs decreased by -$121,000 (-6%) to $1,934,000 in 2025 from $2,055,000 in 2024.</li><li>Marketing and Selling Expenses decreased by -$158,000 (-6%) to $2,657,000 in 2025 from $2,815,000 in 2024.</li><li>General and Administrative Costs increased by $230,000 (13%) to $1,952,000 in 2025 from $1,722,000 in 2024.</li><li>Total Operating Expenses decreased by -$49,000 (-1%) to $6,543,000 in 2025 from $6,592,000 in 2024.</li></ul><h4>Operational Metrics (Three Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Gross Profit increased by $169,000 (7%) to $2,512,000 in 2025 from $2,343,000 in 2024, with gross profit percentage at 50% in 2025 compared to 45% in 2024.</li><li>Operating Income increased by $121,000 (61%) to $319,000 in 2025 from $198,000 in 2024, with operating margin at 6% in 2025 compared to 4% in 2024.</li><li>Net Income increased by $66,000 (24%) to $340,000 in 2025 from $274,000 in 2024.</li><li>Research and Product Development Costs increased by $10,000 (2%) to $638,000 in 2025 from $628,000 in 2024.</li><li>Marketing and Selling Expenses decreased by -$2,000 (0%) to $927,000 in 2025 from $929,000 in 2024.</li><li>General and Administrative Costs increased by $39,000 (7%) to $628,000 in 2025 from $589,000 in 2024.</li><li>Total Operating Expenses increased by $47,000 (2%) to $2,193,000 in 2025 from $2,146,000 in 2024.</li></ul><h4>Cash Flow (Nine Months Ended November 30, 2025 vs. 2024)</h4><ul><li>Net Cash Provided by Operating Activities decreased to $110,000 in 2025 from $1,199,000 in 2024.</li><li>Net Cash Provided by Investing Activities decreased to $224,000 in 2025 from $4,765,000 in 2024.</li><li>Net Cash Used in Financing Activities was -$140,509 in 2025 compared to $0 in 2024.</li><li>Net Increase in Cash and Cash Equivalents decreased to $193,000 in 2025 from $5,964,000 in 2024.</li></ul><h4>Unique Metrics</h4><ul><li>The combined equipment and service-related backlog reached a record $12.26 million at November 30, 2025, representing a 16% year-over-year increase and a 9% sequential increase.</li><li>Foreign sales constituted approximately 37% of total sales during the first nine months of fiscal year 2026, a decrease from 39% in the prior year.</li><li>One customer accounted for 38% of sales during the first nine months of fiscal 2026 and 29% during the third quarter of fiscal 2026, also representing 67% of outstanding accounts receivables at November 30, 2025.</li></ul><h4>Future Outlook and Strategy</h4>Sono-Tek Corporation is shifting its business model towards offering complete machine solutions and higher-value subsystems, which has led to increased average unit selling prices. The company anticipates ongoing sales growth in the medical and alternative energy markets, supported by an expansion of its direct sales force and new distributors. Recent tax law changes are expected to reduce current tax payable for capital expenditures and may generate tax refunds in fiscal year 2026.

Sono-Tek | 10-Q: FY2026 Q3 Revenue Misses Estimate at USD 5.004 M